Kenward Borg Johnson
Physician in Sandy, UT
License number
Utah 320410-1205
Issued Date
Apr 19, 1996
Expiration Date
Jan 31, 2018
Category
Physician
Type
Physician & Surgeon
Address
Address
Sandy, UT
Professional information
Methods And Apparatus For Drug Modeling And Displaying Drug Models
US Patent:
2012019, Aug 2, 2012
Filed:
Jan 27, 2012
Appl. No.:
13/360642
Inventors:
Noah Syroid - Salt Lake City UT, US
Dwayne R. Westenskow - Salt Lake City UT, US
James Agutter - Salt Lake City UT, US
Talmage D. Egan - Salt Lake City UT, US
Kenward B. Johnson - Sandy UT, US
Dwayne R. Westenskow - Salt Lake City UT, US
James Agutter - Salt Lake City UT, US
Talmage D. Egan - Salt Lake City UT, US
Kenward B. Johnson - Sandy UT, US
International Classification:
A61M 31/00
US Classification:
604 9301
Abstract:
Drug delivery models, displays, and systems may be configured to provide a clinician with readily intuitive information about the effects of one or more drugs on a subject. Interactive features may be included to provide a subject-specific model of the expected or predicted effects of one or more drugs on the subject. Additionally, interactive features that effect drug delivery to the subject may also be included. Drug delivery models, displays, and systems may be used in teaching, in advance of treatment, during treatment, or following treatment.
Methods And Apparatus For Drug Modeling And Displaying Drug Models
US Patent:
2008023, Sep 25, 2008
Filed:
Mar 20, 2007
Appl. No.:
11/725864
Inventors:
Noah Syroid - Salt Lake City UT, US
Dwayne R. Westenskow - Salt Lake City UT, US
James Agutter - Salt Lake City UT, US
Talmage D. Egan - Salt Lake City UT, US
Kenward B. Johnson - Sandy UT, US
Dwayne R. Westenskow - Salt Lake City UT, US
James Agutter - Salt Lake City UT, US
Talmage D. Egan - Salt Lake City UT, US
Kenward B. Johnson - Sandy UT, US
International Classification:
A61K 31/4468, A61K 31/05, A61K 31/08, A61K 31/4535, A61K 31/454, A61K 31/02
US Classification:
514326, 514731, 514722, 514743, 514329, 12820312
Abstract:
Drug delivery models, displays, and systems may be configured to provide a clinician with readily intuitive information about the effects of one or more drugs on a subject. Interactive features may be included to provide a subject-specific model of the expected or predicted effects of one or more drugs on the subject. Additionally, interactive features that effect drug delivery to the subject may also be included. Drug delivery models, displays, and systems may be used in teaching, in advance of treatment, during treatment, or following treatment.